% | $
Quotes you view appear here for quick access.

Zalicus AŞ Message Board

  • zeekingofhill zeekingofhill Sep 28, 2013 9:35 AM Flag

    Hey scistats

    You have been working hard on your ide of top line results by end of next week, but according to the CEO comment from yesterdays PR, he says later this year. Now I take that to mean not next week, but maybe something like November. Lets hope that next week we build a strong base above $1 and avoid RS.

    "The FDA’s designation of Z160 as having orphan drug status is an important milestone for Zalicus as we continue the clinical development work required for potential FDA approval of Z160," commented Mark H.N. Corrigan, MD, President and CEO of Zalicus. “We look forward to evaluating and reporting the activity of Z160 in chronic neuropathic pain indications later this year, including postherpetic neuralgia and lumbosacral radiculopathy.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies